Skip to main content
SpringerLink
Log in

A multi-pronged approach required for management of complications of cirrhosis of the liver

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anand BS. Drug treatment of the complications of cirrhosis in the older adult. Drugs & Aging 2001; 18(8): 575–85

    Article  CAS  Google Scholar 

  2. Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998; 27: 264–72

    Article  PubMed  CAS  Google Scholar 

  3. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701–7

    Article  PubMed  CAS  Google Scholar 

  4. Lake JR. The role of transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1745–7

    Article  PubMed  CAS  Google Scholar 

  5. Runyon BA, McHutchinson JG, Antillon MR, et al. Short-course versus long course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology 1991; 100: 1737–42

    PubMed  CAS  Google Scholar 

  6. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403–9

    Article  PubMed  CAS  Google Scholar 

  7. Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12: 716–24

    Article  PubMed  CAS  Google Scholar 

  8. Bernard B, Grange JD, Nguyen Khac E, et al. Antibiotic prophylaxis for prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis. Digestion 1998; 59 Suppl. 2: 54–7

    Article  PubMed  Google Scholar 

  9. Westaby D, Hayes P, Gimson AE, et al. Controlled trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989; 9: 274–7

    Article  PubMed  CAS  Google Scholar 

  10. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332–54

    PubMed  Google Scholar 

  11. Sarin SK, Lamba GS, Kumar M, et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340: 988–93

    Article  PubMed  CAS  Google Scholar 

  12. Conn HO. Animal versus vegetable protein diet in hepatic encephalopathy. J Intern Med 1993; 233: 369–71

    Article  PubMed  CAS  Google Scholar 

  13. Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999; 29: 1691–7

    Article  Google Scholar 

  14. Gulberg V, Bilzer M, Gerbes AL. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 1999; 30: 870–5

    Article  PubMed  CAS  Google Scholar 

  15. Guevara M, Gines P, Bandi JC, et al. Transjugular portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28: 416–2

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A multi-pronged approach required for management of complications of cirrhosis of the liver. Drugs Ther. Perspect 18, 8–11 (2002). https://doi.org/10.2165/00042310-200218060-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218060-00003

Keywords

Search

Navigation